The State of Supplement Evidence (2026)
Supplements are sold on the promise of science. We scored 550 of them on a transparent 0–10 evidence scale, built from 7,902 studies and 1,987 meta-analyses — and looked at what the evidence actually says.
Key findings
- ▸Only 4% of supplements (22 of 550) have "strong" evidence (a score of 8–10).
- ▸55% are limited or insufficient — 11% (1 in 9) don't have enough evidence to be scored at all.
- ▸Experimental compounds (37% of the market) average 4.4/10 versus 5.3/10 for mainstream supplements.
- ▸33% carry a "use with caution" safety rating.
- ▸Popularity ≠ evidence: the most-studied product (Multivitamin, 44 studies) scores only 6/10.
The evidence pyramid
| Tier | Score | Count | Share |
|---|---|---|---|
| Strong | 8–10 | 22 | 4% |
| Moderate | 5–7 | 224 | 41% |
| Limited | 3–4 | 243 | 44% |
| Insufficient | <3 | 61 | 11% |
The evidence-backed dozen
Just 12 supplements clear both bars — strong evidence (8+) and a high safety rating:
Creatine 9.5Whey Protein 9Probiotics 9Omega-3 9Sunscreen (SPF) 9(topical)Psyllium Husk 8.5Zinc 8.5Melatonin 8.5Magnesium 8.5Saccharomyces Boulardii 8.5CoQ10 8Vitamin C 8
Popularity is not evidence
Multivitamin is the most-studied product in the corpus (44 studies) yet scores only 6/10. Being studied a lot and being shown to work are not the same thing.
The experimental-compound gap
About 37% of the supplements we track (201 of 550) are experimental or research compounds. As a group they average 4.4/10 — and 19% don't even have enough evidence to be scored. The marketing energy is aimed squarely at the tier where the evidence is thinnest.
Safety is not a given
183 supplements (33%) carry a "use with caution" safety rating in our data — for drug interactions, contraindicated populations, or dose sensitivity. "Natural" is not a synonym for "harmless."
Methodology & data
SupStack scores each supplement on a transparent 0–10 scale weighting study quantity, study quality (RCTs and meta-analyses over observational data), effect consistency, and effect size. Scores below 3 are treated as "insufficient evidence." The full methodology and underlying data are public.
See the methodology →Browse all supplements →
Cite this: "The State of Supplement Evidence (2026), SupStack — supstack.me." Data snapshot: July 4, 2026.